All quotes are from the papers cited in yesterday's confusing:
"Dutasteride [Avodart] & Abiraterone [Zytiga]?"
1] "Abiraterone is metabolized in patients to D4A" (Δ4-abiraterone)
2] D4A "has even greater anti-tumor activity" than Abiraterone
3] but "D4A is converted to ... 3-keto-5α-abi" (by 5alpha reductase)
4] & 3-keto-5α-abi "promotes prostate cancer progression."
5] Dutasteride prevents the conversion
6] Therefore Dutasteride might enhance (& prolong?) the effectiveness of Abiraterone
-Patrick